Atlas Trials

Clinical Study of SNK01 in Participants With Moderate Alzheimer's Disease

Clinical trial NCT06189963 · RECRUITING

Trial details

NCT number
NCT06189963
Sponsor
NKGen Biotech, Inc.
Status
RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Moderate Alzheimer Disease
Start date
2023-11-21
Primary completion
2026-12-01
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.